8225 studies found for:    Communicable Diseases: Clinical Trials
Show Display Options
Rank Status Study
21 Completed A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Condition: HIV Infections
Intervention: Other: Observation
22 Completed Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
Conditions: Latent Tuberculosis Infection;   Tuberculosis
Interventions: Biological: RUTI;   Biological: RUTI Matching Placebo
23 Recruiting Clinical Trial of Safety and Clinical Efficiency of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children
Condition: Acute Upper Respiratory Tract Infections
Interventions: Drug: Ergoferon;   Drug: Placebo
24 Unknown  CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
25 Recruiting The SCOUT Study: Short Course Therapy for Urinary Tract Infections in Children
Condition: Urinary Tract Infections
Interventions: Drug: Trimethoprim sulfamethoxazole, amoxicillin-clavulanate, cefixime, or cephalexin;   Drug: Placebo
26 Recruiting The Amputation Surgical Site Infection Trial (ASSIT)
Conditions: Wound Infection;   Amputation Wound
Interventions: Drug: Co-amoxiclav;   Drug: Iodine;   Drug: Metronidazole;   Drug: Chlorhexidine;   Drug: Teicoplanin;   Drug: Clindamycin
27 Completed Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection
Condition: MRSA Infection
Interventions: Drug: trimethoprim-sulfamethoxazole (TMP-SMX);   Drug: Linezolid;   Drug: Rifampicin
28 Recruiting Trial to Compare Piperacillin-tazobactam to Meropenem for the Definitive Treatment of Bloodstream Infections Caused by Ceftriaxone Resistant E. Coli or Klebsiella Species.
Condition: Bloodstream Infections
Interventions: Drug: Meropenem;   Drug: Piperacillin-tazobactam combination product
29 Terminated Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
Condition: Tuberculosis
Intervention: Drug: I ( isoniazid), II (isoniazid + rifampin )
30 Recruiting Clinical Trial With Catheter Locking TauroSept® (Taurolidine 2%) or Saline Solution 0,9%
Condition: Catheter Related Blood Stream Infections
Intervention: Device: TauroSept®
31 Completed Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia
Condition: Helicobacter Pylori Infection
Interventions: Drug: Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole);   Drug: Clarithromycin, Amoxicillin, Omeprazole
32 Completed A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP
Condition: HIV Infections
Intervention: Drug: Zidovudine
33 Completed Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical Trial
Conditions: Acute Renal Failure;   Infection
Intervention: Other: Ethanol
34 Recruiting Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
Condition: Latent Tuberculosis Infection
Interventions: Drug: Isoniazid;   Drug: Rifampin
35 Completed
Has Results
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir
36 Active, not recruiting Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV-Peptide-Specific T cells
37 Terminated A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
Conditions: Upper Respiratory Tract Infection;   Influenza
Interventions: Drug: Oseltamivir;   Drug: Zanamivir;   Drug: Placebo of Oseltamivir
38 Active, not recruiting Clinical Trial of Efficacy of Anaferon for Children® in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
Condition: Influenza and Acute Respiratory Viral Infections
Interventions: Drug: Anaferon for children;   Drug: Placebo
39 Completed A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)
Condition: HIV Infections
Interventions: Biological: MTP-PE/MF59;   Biological: Env 2-3
40 Terminated Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Diphenhydramine hydrochloride;   Drug: Lymphocytes, Activated;   Drug: Lamivudine;   Drug: Zidovudine;   Drug: Acetaminophen;   Drug: Aldesleukin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years